At 15x earnings and just 8x forward earnings, BNS is priced like a no-growth bank despite a PEG Forward of 0.9 implying growth is available at a reasonable price. The compression from 15 to 8 on a forward basis suggests either earnings are expected to inflect materially or the market is discounting risk excessively; combined with a 3.7 TTM yield and a 4 Dividend 5-Year Avg (%), investors are being paid to wait. However, the absence of an Altman Z-Score and EPS data limits balance sheet distress visibility, and a modest 4.60% ROE tempers enthusiasm. This is not a pristine compounder, but at 8x forward earnings with institutional ownership at $78.28, it screens as a potentially mispriced income-oriented value play rather than a growth darling.